{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:39:20Z","timestamp":1778395160510,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12350-022-03106-1","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T18:02:41Z","timestamp":1664820161000},"page":"1065-1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["FDG uptake patterns in isolated and systemic cardiac sarcoidosis"],"prefix":"10.1016","volume":"30","author":[{"given":"Koichiro","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinobu","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-022-03106-1_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s12350-022-03106-1_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1007\/s12350-022-03106-1_bib3","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"issue":"383","key":"10.1007\/s12350-022-03106-1_bib4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"M\u00fcller-Quernheim J. Sarcoidosis","volume":"29","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1007\/s12350-022-03106-1_bib5","first-page":"275","article-title":"Causes of death in patients with chronic sarcoidosis","volume":"33","author":"Hu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1007\/s12350-022-03106-1_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/bmb\/ldv033","article-title":"Advances in radionuclide imaging of cardiac sarcoidosis","volume":"115","author":"Kouranos","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1007\/s12350-022-03106-1_bib7","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis: a focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"182","key":"10.1007\/s12350-022-03106-1_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2014.12.056","article-title":"Isolated cardiac sarcoidosis: clinical characteristics, diagnosis and treatment","volume":"1","author":"Isobe","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-022-03106-1_bib10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jcmg.2019.11.021","article-title":"Prognostic value of 18F-FDG PET using texture analysis in cardiac sarcoidosis","volume":"13","author":"Manabe","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03106-1_bib11","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"345","key":"10.1007\/s12350-022-03106-1_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijcard.2021.10.150","article-title":"Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria","volume":"15","author":"Takaya","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib13","article-title":"Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET\/CT","author":"Okada","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"83","key":"10.1007\/s12350-022-03106-1_bib14","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"25","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1007\/s12350-022-03106-1_bib15","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"key":"10.1007\/s12350-022-03106-1_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12350-021-02567-0","article-title":"Prognosis and recurrence in cardiac sarcoidosis: serial assessment of BMIPP SPECT and FDG-PET","volume":"28","author":"Yamamoto","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-022-03106-1_bib18","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-022-03106-1_bib19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-022-03106-1_bib20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib22","first-page":"1522","article-title":"Carter EA Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG","volume":"46","author":"Pellegrino","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-022-03106-1_bib23","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-022-03106-1_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1183\/09031936.00076406","article-title":"Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques","volume":"29","author":"Pandya","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1007\/s12350-022-03106-1_bib25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s12149-014-0860-7","article-title":"Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis","volume":"28","author":"Manabe","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-022-03106-1_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12350-018-1291-y","article-title":"18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes","volume":"27","author":"Tuominen","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib27","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-treatment myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03106-1_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib30","first-page":"229","article-title":"Evaluation of response to steroid therapy for cardiac sarcoidosis using volumetric analysis of 18F-FDG PET\/CT","volume":"9","author":"Maruoka","year":"2017","journal-title":"J Bional Biomed"},{"key":"10.1007\/s12350-022-03106-1_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03106-1_bib32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03106-1_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12350-019-01659-2","article-title":"FDG-PET in possible cardiac sarcoidosis: right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","volume":"28","author":"Tuominen","year":"2021","journal-title":"J Nucl Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-022-03106-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107135812300020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107135812300020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:15Z","timestamp":1761027075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107135812300020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S107135812300020X"],"URL":"https:\/\/doi.org\/10.1007\/s12350-022-03106-1","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FDG uptake patterns in isolated and systemic cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-022-03106-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}